MassMutual Private Wealth & Trust’s Kura Oncology KURA Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.78K	Hold	436	–	–	﹤0.01%	1707
2026 Q1	$3.54K	Hold	436	–	–	﹤0.01%	1801
2025 Q4	$4.53K	Hold	436	–	–	﹤0.01%	1720
2025 Q3	$3.86K	Buy	436 +374	+603%	+$2.67K	﹤0.01%	1776
2025 Q2	$358	Sell	62 -149	-71%	-$913	﹤0.01%	2262
2025 Q1	$1.39K	Buy	+211	New	+$1.64K	﹤0.01%	2030
2024 Q4	–	Sell	-19	Closed	-$371	–	2330
2024 Q3	$371	Hold	19	–	–	﹤0.01%	2020
2024 Q2	$391	Buy	+19	New	+$391	﹤0.01%	1993

Other funds holding KURA

NFT

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

OAM

OP Asset Management Helsinki $9.38B AUM 42.35% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

XWM

Xcel Wealth Management Holly Hill, Florida $419M AUM 30.44% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

ACM

ACT Capital Management Wayne, Pennsylvania $153M AUM

MassMutual Private Wealth & Trust's KURA Position: Q2 2026 in Review

MassMutual Private Wealth & Trust held its Kura Oncology (KURA) position steady in Q2 2026 at 436 shares worth $4.78K. The position accounts for ﹤0.01% of the portfolio, ranked #1707.

MassMutual Private Wealth & Trust first reported a position in KURA in Q2 2024 and has held it in 8 quarters since. 42 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

MassMutual Private Wealth & Trust held 436 shares of Kura Oncology worth $4.78K as of Q2 2026.
MassMutual Private Wealth & Trust left its Kura Oncology share count unchanged in Q2 2026.
Kura Oncology made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1707 holding.
MassMutual Private Wealth & Trust first reported a position in Kura Oncology in Q2 2024 and has held it in 8 quarters since.
42 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.